C
Claire Lemanski
Researcher at University of Montpellier
Publications - 84
Citations - 2836
Claire Lemanski is an academic researcher from University of Montpellier. The author has contributed to research in topics: Radiation therapy & Breast cancer. The author has an hindex of 27, co-authored 76 publications receiving 2540 citations.
Papers
More filters
Journal ArticleDOI
Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial
Didier Peiffert,Laetitia Tournier-Rangeard,Jean-Pierre Gerard,Claire Lemanski,Eric Francois,Marc Giovannini,Frédérique Cvitkovic,Xavier Mirabel,Olivier Bouché,Elisabeth Luporsi,Thierry Conroy,C. Montoto-Grillot,Françoise Mornex,Antoine Lusinchi,Jean-Michel Hannoun-Levi,Jean-François Seitz,Antoine Adenis,Christophe Hennequin,Bernard Denis,Michel Ducreux +19 more
TL;DR: Using CFS as the main end point, this trial did not find an advantage for either ICT or HD radiation boost in LAACC, and the results of the most treatment-intense arm B should prompt the design of further intensification studies.
Journal ArticleDOI
Aspiration rate following chemoradiation for head and neck cancer: An underreported occurrence
Nam P. Nguyen,Cheryl Frank,Candace C. Moltz,Paul Vos,Herbert J. Smith,Prabhakar V. Bhamidipati,Ulf Karlsson,Phuc D. Nguyen,Alan A. Alfieri,Ly M. Nguyen,Claire Lemanski,Wayne Chan,Sue Rose,Sabah Sallah +13 more
TL;DR: Aspiration remained a significant morbidity following chemoradiation for head and neck cancer and its prevalence is underreported in the literature because of its often silent nature.
Journal ArticleDOI
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.
Bruno Cutuli,C. Cohen-Solal Le-Nir,D. Serin,Youlia M. Kirova,Z. Gaci,Claire Lemanski,B. De Lafontan,M. Zoubir,P. Maingon,Hervé Mignotte,C. Tunon de Lara,Julien Edeline,Frédérique Penault-Llorca,Pascale Romestaing,Catherine Delva,B. Comet,Yazid Belkacemi +16 more
TL;DR: Earlier diagnosis and wide use of adjuvant treatments (RT/HT/CT) widely decreased LR and increased survival rates in MBC, reaching female ones and axillary nodal involvement and high SBR remain prognostic factors.
Journal ArticleDOI
Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers’ experience
Bruno Cutuli,Christine Cohen-Solal-le Nir,Brigitte de Lafontan,Hervé Mignotte,V. Fichet,R. Fay,Véronique Servent,Sylvia Giard,C. Charra-Brunaud,Claire Lemanski,H. Auvray,Stephane Jacquot,Jean-Christophe Charpentier +12 more
TL;DR: The long-term outcome for women with ductal carcinoma in situ of the breast treated in current clinical practice by conservative surgery with or without definitive breast irradiation is extremely consistent with the updated National Surgical Adjuvant Breast Project B17 and European Organization for Research and Treatment of Cancer 10853 trials.
Journal ArticleDOI
Phase III Randomized Trial of Very Accelerated Radiation Therapy Compared With Conventional Radiation Therapy in Squamous Cell Head and Neck Cancer: A GORTEC Trial
Jean Bourhis,Michel Lapeyre,Jacques Tortochaux,Michel Rives,Mehdi Aghili,Sylvain Bourdin,François Lesaunier,Toufik Benassi,Claire Lemanski,Lionel Geoffrois,Antoine Lusinchi,Pierre Verrelle,Etienne Bardet,Morbize Julieron,Pierre Wibault,M. Luboinski,Ellen Benhamou +16 more
TL;DR: The very accelerated RT regimen was feasible and provided a major benefit in locoregional control but had a modest effect on survival.